Healthcare >> CEO Interviews >> May 6, 2002
MARK J. BUSGANG is President and Chief Executive Officer of
Warnex Inc. Mr. Busgang has been involved at the executive level
as a manager and investor in the pharmaceutical industry since
1980. One of the many directorships and management positions he
has held was as principal founder of Theratechnologies Inc., a
highly successful publicly traded biotechnology company listed on
the Toronto Stock Exchange. Mr. Busgang received his Bachelor of
Commerce degree from Concordia University. He then went on to
earn a Master's of Business Administration from the prestigious
Graduate School of Business at Fordham University in New York.
One of his many senior management positions was as President of
Pharmetics Ltd. from 1993 until 1996. It was in this capacity
that he was instrumental in establishing Theratechnologies, which
subsequently purchased Pharmetics, a contract manufacturing
facility serving the pharmaceutical industry. Upon leaving
Theratechnologies in 1996 to pursue other business interests, Mr.
Busgang created his own private venture capital investment
company. That development led to his direct involvement in Warnex
Inc. Mr. Busgang has played a leadership role within the Canadian
pharmaceutical industry. He was Vice President of the National
Health Products Association from 1990-1996; a Director of the
Canadian Health Foods Association from 1989-1993; and a Director
of the Provincial Association of Qubec-based pharmaceutical
manufacturers from 1987-1990. In addition, he acted as Industry
representative on the Task Force for Drug Product Licensing. Mr.
Busgang is a member of the YPO (Young President's Association),
past President of the Green Valley Golf & Country Club and is
active in social and community affairs. Profile
Inc., and an overview of what you are doing at the present time?
Mr. Busgang: Warnex is a publicly traded company on the
